Detalhe da pesquisa
1.
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.
J Viral Hepat
; 26(9): 1040-1049, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972912
2.
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection.
Hepatology
; 62(4): 1013-23, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26118427
3.
Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study.
J Gastroenterol Hepatol
; 31(11): 1874-1881, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26997582
4.
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection.
J Gastroenterol Hepatol
; 30(1): 184-91, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24995515
5.
Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.
Hepatology
; 58(3): 872-80, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553752
6.
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.
J Hepatol
; 55(5): 1121-31, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21718667
7.
Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa.
Clin Liver Dis
; 25(4): 741-762, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593151
8.
Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a.
Gastroenterology
; 136(7): 2169-2179.e1-4, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19303414
9.
Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.
Gastroenterology
; 137(6): 2002-9, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19737568
10.
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.
Hepatology
; 49(4): 1141-50, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19338056
11.
Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon.
Liver Int
; 30(5): 657-68, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20158610
12.
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B.
PLoS One
; 15(4): e0230893, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275726
13.
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
Hepatology
; 47(2): 428-34, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18220290
14.
Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data.
Antivir Ther
; 24(2): 133-140, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865588
15.
Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
Asian Pac J Cancer Prev
; 20(4): 1257-1264, 2019 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31030503
16.
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
N Engl J Med
; 352(26): 2682-95, 2005 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15987917
17.
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a.
Liver Int
; 28(4): 477-85, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18339074
18.
No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
PLoS One
; 13(7): e0199198, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016335
19.
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
N Engl J Med
; 351(12): 1206-17, 2004 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-15371578
20.
Further analysis is required to identify an early stopping rule for peginterferon therapy that is valid for all hepatitis B e antigen-positive patients.
Hepatology
; 53(3): 1054-5; author reply 1055, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21374671